- Trials with a EudraCT protocol (395)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
395 result(s) found for: Intravitreal injection.
Displaying page 1 of 20.
EudraCT Number: 2008-006265-93 | Sponsor Protocol Number: AVO1 | Start Date*: 2009-03-11 |
Sponsor Name:St Eriks Eye Hospital | ||
Full Title: A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin®) for central retinal vein occlusion (CRVO). | ||
Medical condition: Central retinal vein occlusion (CRVO) is a sight-threatening ocular condition without efficient treatment. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000103-27 | Sponsor Protocol Number: Eylea-2014 | Start Date*: 2014-03-12 |
Sponsor Name: | ||
Full Title: Plasma levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept in patients with exudative age-related macular degeneration. | ||
Medical condition: Exudative age-related macular degeneration (AMD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004203-39 | Sponsor Protocol Number: FNKV-OFT-2013-1 | Start Date*: 2014-04-03 |
Sponsor Name:Fakultní nemocnice Královské Vinohrady | ||
Full Title: A randomized, 12 months, active controlled study of the efficacy of repeated doses of intravitreal aflibercept in subjects with prolipherative diabetic retinopathy | ||
Medical condition: prolipherative diabetic retinopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005700-24 | Sponsor Protocol Number: SC | Start Date*: 2015-08-17 | |||||||||||
Sponsor Name:Abteilung für Augenheilkunde, AKH Linz | |||||||||||||
Full Title: Aqueous Humor cytokine Levels following intravitreal ranibizumab or dexamethasone therapy in patients with diabetic macular edema | |||||||||||||
Medical condition: Diabetic Retinopathy and diabetic macular edema are leading causes for visual loss and blindness in young adults around the world. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005556-25 | Sponsor Protocol Number: OFT-ETAMSILATO-4.2.2 | Start Date*: 2015-05-11 |
Sponsor Name:Investigacion Independiente | ||
Full Title: Open extension study for patients with age related macula degeneration who participated in the Fase IV-II clinical trial randomized, simulatedcontrolled treatment to evaluate safety and efficacy o... | ||
Medical condition: Aged related macula degeneration (ARMD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002155-10 | Sponsor Protocol Number: AHM001 | Start Date*: 2016-05-29 | |||||||||||
Sponsor Name:FISEVI Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla | |||||||||||||
Full Title: Effect of topical bromfenac 0.9 mg / ml in the perception of pain after intravitreal injection of drugs | |||||||||||||
Medical condition: Following the intravitreal injection of various drugs, very common procedure in clinical practice in ophthalmology, pain often occurs to varying degrees, although in most cases it is a painless pro... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003976-36 | Sponsor Protocol Number: CBPD952ABE02 | Start Date*: 2006-09-01 |
Sponsor Name:Professor Anita Leys - Dienst Oftalmologie UZ St. Rafaël | ||
Full Title: An academic monocenter study assessing the safety and efficacy of Lucentis (ranizumab 0.3 mg) administered in conjunction with photodynamic therapy with Visudyne in patients with occult or predomi... | ||
Medical condition: Male and female patients ≥50 years of age with subfoveal choroidal neovascularisation lesions secondary to age related macular degeneration, either predominantly classic or occult with no classic c... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005462-12 | Sponsor Protocol Number: LUTA1 | Start Date*: 2007-12-11 |
Sponsor Name:St. Eriks Eye Hospital | ||
Full Title: A prospective, randomized, masked and controlled trial of intravitreal ranibizumab (Lucentis®) combined with transpupillary thermotherapy (TTT) in patients with neovascular age-related macular dege... | ||
Medical condition: Age-related macular degeneration (AMD) is the leading cause of visual impairment and social blindness in people 60 years or older. Approximately 80% of patients with severe visual loss exhibit neov... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000658-30 | Sponsor Protocol Number: prot PDR 1 | Start Date*: 2007-03-02 |
Sponsor Name:Royal Victoria Eye and Ear hospital | ||
Full Title: Randomised controlled trial of Intravitreal Bevacizumab vs. conventional treatment for proliferative diabetic retinopathy. | ||
Medical condition: Proliferative diabetic retinopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000585-21 | Sponsor Protocol Number: prot RG 1 | Start Date*: Information not available in EudraCT |
Sponsor Name:Royal Victoria Eye and Ear hospital | ||
Full Title: Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glaucoma. | ||
Medical condition: Rubeotic glaucoma secondary to ischaemic proliferative retinopathies | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001914-34 | Sponsor Protocol Number: 01052006 | Start Date*: 2006-08-30 |
Sponsor Name:Bert Mueller, Dep. Ophthalmology | ||
Full Title: Treatment of neovascular age related macular degeneration with intravitreal Bevacizumab (Avastin) | ||
Medical condition: neovascular age-related macular degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001385-14 | Sponsor Protocol Number: IOBA-01-2004 | Start Date*: 2006-01-23 |
Sponsor Name:IOBA. FACULTAD DE MEDICINA | ||
Full Title: Evaluacion de la eficacia y seguridad de la inyección intravítrea de triamcinolona en el tratamiento del edema difuso del diabético | ||
Medical condition: DIFFUSE DIABETIC MACULAR OEDEMA | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003170-99 | Sponsor Protocol Number: IVB JSA | Start Date*: 2007-07-24 | |||||||||||
Sponsor Name:UNIVERSITA DEGLI STUDI DI UDINE | |||||||||||||
Full Title: Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration | |||||||||||||
Medical condition: Exudative age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005400-14 | Sponsor Protocol Number: WONR1001 | Start Date*: 2008-07-25 | |||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | |||||||||||||
Full Title: PERIOPERATIVE INTRAVITREAL TRIAMCINOLONE IN PHAKOEMULSIFICATION FOR CONCURRENT CLINICALLY SIGNIFICANT DIABETIC MACULAR OEDEMA | |||||||||||||
Medical condition: Diabetic Maculopathy: Clinically significant macular oedema To understand the effects of intravitreal triamcinolone (IVTA) in the treatment of clinically significant macular edema (CSME) in diabet... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001781-15 | Sponsor Protocol Number: IOBA-04-2012 | Start Date*: 2012-07-31 | |||||||||||
Sponsor Name:IOBA, Universidad de Valladolid | |||||||||||||
Full Title: Initial protocol setting for the treatment of choroidal neovascularization associated to myopia magna with intravitreal bevacizumab: 3 vs 1 (BENEMCOR.es study) | |||||||||||||
Medical condition: choroidal neovascularization associated to myopia magna | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017540-13 | Sponsor Protocol Number: | Start Date*: 2010-07-27 | |||||||||||
Sponsor Name:Clinical Trials and Research Governance | |||||||||||||
Full Title: A Phase IV Open-Labelled Prospective Pilot Study of Intravitreal Macugen (pegaptanib) for Ischaemic Diabetic Macular Oedema (MIDME study) | |||||||||||||
Medical condition: Ischaemic diabetic macular oedema. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000961-10 | Sponsor Protocol Number: NITRO Protocol | Start Date*: 2011-12-07 | |||||||||||
Sponsor Name:Royal Liverpool and Broadgreen University Hospitals Trust | |||||||||||||
Full Title: Neoadjuvant IntraviTreal Ranibizumab treatment in high risk Ocular melanoma patients: A two stage single centre Phase II single arm study (NITRO Trial) | |||||||||||||
Medical condition: Uveal Melanoma (requiring enucleation) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001869-41 | Sponsor Protocol Number: OKHN1005 | Start Date*: 2011-08-24 | ||||||||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: An exploratory study of ranibizumab (Lucentis) for treatment of uveitic patients with refractory cystoid macular oedema. 'The LIMO study' | ||||||||||||||||||
Medical condition: Uveitic Macular Oedema | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-000397-45 | Sponsor Protocol Number: OY060301 | Start Date*: 2005-06-02 |
Sponsor Name:Queen's Medical centre | ||
Full Title: Randomised Controlled Trial Of Intravitreal Triamcinolone In Patients With Diabetic Macular Oedema Refractory To Laser Treatment | ||
Medical condition: Diabetic macular oedema affecting vision and refractory to laser treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003272-12 | Sponsor Protocol Number: SIVS1012 | Start Date*: 2014-04-08 |
Sponsor Name:Moorfields Eye Hospital | ||
Full Title: Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy | ||
Medical condition: Proliferative Diabetic Retinopathy (PDR) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
